Christopher L. Cook

Christopher L. Cook serves as a key procurement professional within the Naval Medical Logistics Command, supporting the Department of Defense’s mission to sustain combat-ready medical forces through the acquisition of critical diagnostic, surgical, and life-sustaining medical systems. He manages a diverse portfolio of contracts focused on advanced medical technologies, including analytical laboratory instruments, in-vitro diagnostic substances, and surgical devices essential for point-of-care and field-deployable clinical operations. His acquisitions are strategically aligned with the Navy and Marine Corps’ need for resilient, rapidly deployable medical logistics, ensuring operational continuity across global theaters. Cook’s contracting patterns reflect a preference for open competition, with approximately 88% of procurements conducted without set-asides, indicating a focus on broad market access to meet urgent operational requirements. The remaining 12% are awarded under Total Small Business Set-Asides, demonstrating a deliberate but measured commitment to small business participation without compromising mission-critical supply chain reliability. While specific vendor names are not publicly disclosed, his engagement spans established medical technology manufacturers and innovative small firms capable of delivering FDA-regulated diagnostic and surgical products under strict military specifications. His procurement focus centers on NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 335413 (In-Vitro Diagnostic Substance Manufacturing), reflecting deep technical expertise in laboratory automation, rapid pathogen detection, and molecular diagnostics. He also regularly procures surgical instruments and medical supplies under NAICS 339112 and 339113, ensuring compatibility with expeditionary medical platforms. His domain expertise includes FDA-cleared, military-qualified medical devices and systems requiring compliance with MIL-STD and IEC 60601 standards, underscoring his role in bridging commercial innovation with military medical readiness.